Department of Neuroscience, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois 60064-3095.
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon 97239-3098.
eNeuro. 2021 Oct 8;8(5). doi: 10.1523/ENEURO.0220-21.2021. Print 2021 Sep-Oct.
Relapse is a major challenge to the treatment of substance use disorders. A progressive increase in cue-induced drug craving, termed incubation of craving, is observed after withdrawal from multiple drugs of abuse in humans and rodents. Incubation of cocaine craving involves the strengthening of excitatory synapses onto nucleus accumbens (NAc) medium spiny neurons via postsynaptic accumulation of high-conductance Ca-permeable AMPA receptors. This enhances reactivity to drug-associated cues and is required for the expression of incubation. Additionally, incubation of cocaine craving is associated with loss of the synaptic depression normally triggered by stimulation of metabotropic glutamate receptor 5 (mGlu5), leading to endocannabinoid production, and expressed presynaptically via cannabinoid receptor 1 activation. Previous studies have found alterations in mGlu5 and Homer proteins associated with the loss of this synaptic depression. Here we conducted coimmunoprecipitation studies to investigate associations of diacylglycerol lipase-α (DGL), which catalyzes formation of the endocannabinoid 2-arachidonylglycerol (2-AG), with mGlu5 and Homer proteins. Although these interactions were unchanged in the NAc core at incubation-relevant withdrawal times, the association of DGL with total and phosphorylated Ca/calmodulin-dependent protein kinase IIα (CaMKIIα) and CaMKIIβ was increased. This would be predicted, based on other studies, to inhibit DGL activity and therefore 2-AG production. This was confirmed by measuring DGL enzymatic activity. However, the magnitude of DGL inhibition did not correlate with the magnitude of incubation of craving for individual rats. These results suggest that CaMKII contributes to the loss of mGlu5-dependent synaptic depression after incubation, but the functional significance of this loss remains unclear.
复发是物质使用障碍治疗的主要挑战。在人类和啮齿动物从多种滥用药物中戒断后,观察到线索诱导的药物渴望逐渐增加,称为渴望孵化。可卡因渴望的孵化涉及通过突触后高电导钙渗透性 AMPA 受体的积累增强对伏隔核(NAc)中间神经元的兴奋性突触。这增强了对药物相关线索的反应性,是孵化表达所必需的。此外,可卡因渴望的孵化与通常由代谢型谷氨酸受体 5(mGlu5)刺激触发的突触抑制的丧失有关,导致内源性大麻素的产生,并通过大麻素受体 1 的激活表达在突触前。先前的研究发现与这种突触抑制丧失相关的 mGlu5 和 Homer 蛋白的改变。在这里,我们进行了共免疫沉淀研究,以研究二酰基甘油脂肪酶-α(DGL)与 mGlu5 和 Homer 蛋白的关联,DGL 催化内源性大麻素 2-花生四烯酰甘油(2-AG)的形成。尽管在与孵化相关的戒断时间内,NAc 核心中的这些相互作用没有改变,但 DGL 与总和磷酸化钙/钙调蛋白依赖性蛋白激酶 IIα(CaMKIIα)和 CaMKIIβ的关联增加。根据其他研究,这将预测抑制 DGL 活性,从而抑制 2-AG 的产生。通过测量 DGL 酶活性证实了这一点。然而,DGL 抑制的幅度与个体大鼠渴望孵化的幅度没有相关性。这些结果表明 CaMKII 有助于孵化后 mGlu5 依赖性突触抑制的丧失,但这种丧失的功能意义仍不清楚。